The Venture Codex

Led · Seed · Aug 2025

Sarborg Limited is a Wilmington, DE–based technology-driven company that integrates mathematical algorithm-led approaches with complementary cybernetics and extensive neural networks to optimize decision-making processes. It combines proprietary AI agents and algorithmic strategies to evaluate drug repurposing by matching drug and disease signatures for pharmaceutical companies. The company's principal vertical focuses on leveraging machine learning to enhance asset portfolio management and improve the probability of success in clinical trials. Sarborg plans to expand its analytic capabilities beyond pharmaceuticals into additional analytic areas. The company raised $10M in Seed funding and intends to use the proceeds to advance its AI agents for drug repurposing, target identification, and clinical trial optimization, and to develop novel pharmaceutical IP through solid-form engineering and formulation expertise. It also aims to grow an internal pipeline for monetization via outlicensing or royalty-based deals and to expand its revenue-generating services to fund ongoing innovation and reduce future dilution.